# Changes of Muramyl Dipeptide in Intestinal and Extra-intestinal Diseases

> **NCT04924686** · — · UNKNOWN · sponsor: **Zhujiang Hospital** · enrollment: 600 (estimated)

## Conditions studied

- Colorectal Cancer
- Inflammatory Bowel Disease
- Atherosclerotic Cardiovascular Disease
- Type2 Diabetes Mellitus

## Interventions

- **OTHER:** Observational studies, no intervention

## Key facts

- **NCT ID:** NCT04924686
- **Lead sponsor:** Zhujiang Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-05-10
- **Primary completion:** 2023-06-10
- **Final completion:** 2023-08-15
- **Target enrollment:** 600 (ESTIMATED)
- **Last updated:** 2021-06-14

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04924686

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04924686, "Changes of Muramyl Dipeptide in Intestinal and Extra-intestinal Diseases". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT04924686. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*